NCT00310128 2016-02-03Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's LymphomaAIDS Malignancy ConsortiumPhase 2 Withdrawn